help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pammer, J.
Right arrow Articles by Tschachler, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pammer, J.
Right arrow Articles by Tschachler, E.

American Journal of Pathology, Vol 148, 1387-1396, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma

J Pammer, A Plettenberg, W Weninger, B Diller, M Mildner, A Uthman, W Issing, M Sturzl and E Tschachler
Institute of Clinical Pathology, University of Vienna Medical School, Austria.

The CD40 antigen is a member of the tumor necrosis factor receptor/nerve growth factor receptor superfamily and is involved in cell proliferation, differentiation, and survival. Using different monoclonal antibodies, we found CD40 expression by immunohistochemistry on CD31- and CD34-positive Kaposi's sarcoma spindle cells in all tumors of 18 HIV-1 seropositive and 4 HIV-1 seronegative patients. Western blot analysis of tumor lysates detected a 48- to 50-kd glycoprotein corresponding to the CD40 antigen expressed by B lymphocytes. CD40 expression was also detectable in one of four cultures of spindle cells derived from Kaposi sarcoma tissue. Treatment of the CD40-positive spindle cells but not of the CD40-negative ones with interferon-gamma up-regulated CD40 surface expression. Besides on Kaposi sarcoma tumor cells, CD40 was distinctly present on vascular endothelial cells in areas within and adjacent to the tumors and in benign inflammatory lesions such as granulation tissue of HIV-1-negative patients. In contrast, CD34-negative endothelia of thin walled vessels, most likely lymphatics, were predominantly CD40 negative. Only faint or no CD40 expression was found on endothelial cells in normal skin. We conclude from our data that expression of the CD40 antigen by endothelial cells is up-regulated during tissue inflammation. As signaling through CD40 is able to increase cell survival, expression of CD40 by Kaposi sarcoma tumor cells might play an important role in the pathogenesis of this neoplasm.


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
C. Chiodoni, M. Iezzi, C. Guiducci, S. Sangaletti, I. Alessandrini, C. Ratti, F. Tiboni, P. Musiani, D. N. Granger, and M. P. Colombo
Triggering CD40 on endothelial cells contributes to tumor growth
J. Exp. Med., October 30, 2006; 203(11): 2441 - 2450.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Bergmann and P. P. Pandolfi
Giving blood: a new role for CD40 in tumorigenesis
J. Exp. Med., October 30, 2006; 203(11): 2409 - 2412.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. W. Henderson, R. Ruhl, P. Lewis, M. Bentley, J. A. Nelson, and A. V. Moses
Human Immunodeficiency Virus (HIV) Type 1 Vpu Induces the Expression of CD40 in Endothelial Cells and Regulates HIV-Induced Adhesion of B-Lymphoma Cells
J. Virol., May 1, 2004; 78(9): 4408 - 4420.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Ottaiano, A. De Chiara, F. Perrone, G. Botti, F. Fazioli, V. De Rosa, N. Mozzillo, V. Ravo, B. Morrica, C. Gallo, et al.
Prognostic Value of CD40 in Adult Soft Tissue Sarcomas
Clin. Cancer Res., April 15, 2004; 10(8): 2824 - 2831.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. S. Kornbluth
The emerging role of CD40 ligand in HIV infection
J. Leukoc. Biol., September 1, 2000; 68(3): 373 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Biancone, V. Cantaluppi, M. Boccellino, L. Del Sorbo, S. Russo, A. Albini, I. Stamenkovic, and G. Camussi
Activation of CD40 Favors the Growth and Vascularization of Kaposi's Sarcoma
J. Immunol., December 1, 1999; 163(11): 6201 - 6208.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Pammer, W. Weninger, and E. Tschachler
Human Keratinocytes Express Cellular Prion-Related Protein in Vitro and during Inflammatory Skin Diseases
Am. J. Pathol., November 1, 1998; 153(5): 1353 - 1358.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. C. Sirianni, L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, et al.
gamma -Interferon Production in Peripheral Blood Mononuclear Cells and Tumor Infiltrating Lymphocytes From Kaposi's Sarcoma Patients: Correlation With the Presence of Human Herpesvirus-8 in Peripheral Blood Mononuclear Cells and Lesional Macrophages
Blood, February 1, 1998; 91(3): 968 - 976.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Francisco, S. L. Gawlak, and C. B. Siegall
Construction, Expression, and Characterization of BD1-G28-5 sFv, a Single-chain Anti-CD40 Immunotoxin Containing the Ribosome-inactivating Protein Bryodin 1
J. Biol. Chem., September 26, 1997; 272(39): 24165 - 24169.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.